Clinical and laboratory characteristics of dengue and COVID-19 coinfected patients in Dhaka, Bangladesh.

Abstract

BACKGROUND:

Dengue-COVID-19 coinfection is one of the greatest emerging challenges in dengue-endemic areas during the continuing pandemic. With coinciding clinical and laboratory pictures, early diagnosis becomes burdensome, with management discrepancy.

METHODS:

A descriptive study was performed on dengue-COVID-19 coinfected patients during July-August 2021 for an overview of disease progression, severity and outcome. A total of 11 patients who were positive for dengue NS1 and/or antidengue IgM were included in this study.

RESULTS:

In total, 45.5% patients developed severe COVID-19 disease, 45.5% patients developed group B dengue fever and 9% patients developed group C dengue fever. Concurrent severity of both diseases was seen to be rare, except for in one patient.

CONCLUSION:

Early diagnosis and compatible management still stand as basic principles to prevent fatality and morbidity.

• Authors: Tabiha Binte Hannan, Zazeba Hossain, Md Nazmul Hasan, Abed Hussain Khan, Md Rafiqul Alam, Md Mujibur Rahman, Shohael Mahmud Arafat, Fazle Rabbi Chowdhury
• Journal: Transactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) Vol. 117 Issue 1 Pg. 50-54 (01 03 2023) ISSN: 1878-3503 [Electronic] England
• PMID: 35443278 (Publication Type: Journal Article)
• Copyright: © The Author(s) 2022. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.

Topics

• Humans
• COVID-19 (epidemiology)
• Dengue (complications, diagnosis, epidemiology)
• Bangladesh (epidemiology)
• Coinfection
• Pandemics